Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Healthcare Plans

CVS Health Corporation is an integrated pharmacy health care provider. The Company"s offerings include pharmacy benefit management services; mail order, retail and specialty pharmacy; disease management programs; and retail clinics. The Company operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico.
Website: cvshealth.com



Growth: Pretty weak revenue growth rate 8.2%, there is slowdown compared to average historical growth rates 19.3%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -2.1%

Profitability: LTM net profit margin is positive, +1.6%. In the last quarter the company beat the estimated EPS, +5.3%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.12 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 3.5%.

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 77.8% higher than minimum and 13.4% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, Net Income margin, industries and geography on average are valued 2.4x by P / Sales multiple , the company can be >100% undervalued

Key Financials (Download financials)

Ticker: CVS
Share price, USD:  (+1.1%)77.83
year average price 71.27  


year start price 66.37 2025-02-13

min close price 58.75 2025-07-24

max close price 83.87 2026-01-26

current price 77.83 2026-02-12
Common stocks: 1 311 310 027

Dividend Yield:  3.5%
P / E LTM: 15.5x
P / E annualized: 8.5x
Last revenue growth (y/y):  +19.5%
Last growth of Net Income (y/y):  +160.1%
Historical revenue growth:  +19.3%
Historical growth of Net Income:  -8.1%
P / Sales: 0.3x
Margin (Net Income LTM / Revenue): 1.6%
Fundamental value created in LTM:
Market Cap ($m): 99 266
Price to Book: 1.4x

Revenue and Net Income

Quarterly values ($m)

Change (y/y)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-02-07fool.com

Should You Buy CVS Health Stock Before Feb. 10?

2026-02-06prnewswire.com

CVS Pharmacy Now Accepting TrumpRx Discount Cards

2026-02-04zacks.com

Will Pharmacy and Consumer Wellness Segment Lead CVS' Q4 Earnings?

2026-01-30zacks.com

Why CVS Health (CVS) is a Top Value Stock for the Long-Term

2026-01-28forbes.com

Is CVS Stock The Best Of The Worst?

2026-01-26cnbc.com

Health insurers tumble after Trump administration proposes keeping Medicare Advantage rates flat next year

2026-01-24fool.com

2 Dirt Cheap Stocks to Buy With $200 Right Now

2026-01-23prnewswire.com

CVS Health supports communities as major winter storm approaches

2026-01-22zacks.com

CVS Health (CVS) Exceeds Market Returns: Some Facts to Consider

2026-01-22prnewswire.com

CVS Health® makes health insurance simpler and more affordable for Americans
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803
fillingDate 2025-10-29 2025-07-31 2024-11-06 2024-08-07 2024-05-01 2023-11-01 2023-08-02 2023-05-03 2022-11-02
acceptedDate 2025-10-29 06:34:58 2025-07-31 06:34:19 2025-02-12 06:47:38 2024-11-06 06:35:35 2024-08-07 06:35:29 2024-05-01 06:40:00 2024-02-07 06:52:35 2023-11-01 06:38:24 2023-08-02 06:36:58 2023-05-03 06:38:46 2023-02-08 06:37:38 2022-11-02 06:36:26 2022-02-09 06:37:35 2021-02-16 06:47:54
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 102 871M 98 915M 372 809M 95 428M 91 324M 87 983M 357 776M 89 764M 88 921M 85 278M 322 467M 81 159M 292 111M 268 706M
costOfRevenue 89 065M 85 322M 321 408M 82 870M 77 851M 75 876M 303 345M 140 762M 75 318M 71 903M 267 965M 67 784M 239 991M 219 660M
grossProfit 13 806M 13 593M 51 401M 12 558M 13 473M 12 107M 54 431M -50 998M 13 603M 13 375M 54 502M 13 375M 52 120M 49 046M
grossProfitRatio 0.134 0.137 0.132 0.148 0.138 -0.568 0.153 0.157 0.165
researchAndDevelopmentExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
generalAndAdministrativeExpenses 0 0 40 240M 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 989M 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 0 0 41 229M 0 10 236M 10 230M 0 9 782M 0 0 0 0 0 0
otherExpenses 17 013M 11 212M 1 656M 11 726M 24M 35M 40 688M 9 876M 22M 9 580M 46 548M 9 606M 38 810M 35 135M
operatingExpenses 17 013M 11 212M 42 885M 11 726M 10 236M 10 265M 40 688M 9 876M 9 873M 9 580M 46 548M 9 606M 38 810M 35 135M
costAndExpenses 106 078M 96 534M 364 293M 93 386M 88 087M 86 141M 344 033M 150 638M 85 191M 81 483M 314 513M 77 390M 278 801M 254 795M
interestIncome 0 0 0 0 0 0 0 416M 0 0 0 0 0 0
interestExpense 784M 763M 2 958M 752M 732M 716M 2 658M 693M 686M 589M 2 287M 566M 2 503M 2 907M
depreciationAndAmortization 1 134M 1 171M 4 597M 1 161M 1 151M 1 138M 4 366M 1 127M 1 104M 1 372M 4 224M 1 056M 4 486M 4 441M
ebitda -1 564M 3 581M 13 683M 2 012M 4 215M 3 015M 18 197M 3 690M 4 856M 4 818M 12 347M 4 866M 17 526M 17 118M
ebitdaratio -0.015 0.036 0.021 0.048 0.034 0.041 0.055 0.056 0.06
operatingIncome -3 207M 2 381M 8 516M 832M 3 237M 1 877M 13 743M 3 690M 3 234M 3 446M 7 954M 3 810M 13 310M 13 911M
operatingIncomeRatio -0.031 0.024 0.009 0.035 0.021 0.041 0.036 0.04 0.047
totalOtherIncomeExpensesNet -275M -734M -2 368M -727M -708M -297M -2 570M -671M -474M -567M -2 118M -8 266M -2 773M -4 141M
incomeBeforeTax -3 482M 1 647M 6 148M 105M 2 337M 1 580M 11 173M 3 019M 2 570M 2 879M 5 836M -4 456M 10 537M 9 770M
incomeBeforeTaxRatio -0.034 0.017 0.001 0.026 0.018 0.034 0.029 0.034 -0.055
incomeTaxExpense 508M 634M 1 562M 34M 569M 456M 2 805M 754M 656M 737M 1 509M -1 047M 2 548M 2 569M
netIncome -3 975M 1 021M 4 614M 87M 1 770M 1 113M 8 344M 2 261M 1 901M 2 136M 4 311M -3 409M 8 001M 7 179M
netIncomeRatio -0.039 0.01 0.001 0.019 0.013 0.025 0.021 0.025 -0.042
eps -3.13 0.81 3.66 0.069 1.41 0.88 6.49 1.76 1.48 1.66 3.29 -2.59 6 5.48
epsdiluted -3.13 0.8 0.069 1.41 0.88 1.75 1.48 1.65 -2.59
weightedAverageShsOut 1 269M 1 266M 1 259M 1 259M 1 256M 1 260M 1 285M 1 287M 1 283M 1 283M 1 312M 1 315M 1 319M 1 309M
weightedAverageShsOutDil 1 269M 1 270M 1 262M 1 259M 1 259M 1 267M 1 290M 1 290M 1 287M 1 291M 1 323M 1 315M 1 329M 1 314M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-12 2024-02-07 2023-02-08 2022-02-09 2021-02-16
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -2 958M -2 658M -2 287M -2 503M -2 907M
ebit 9 106M 13 831M 8 123M 13 040M 12 677M
nonOperatingIncomeExcludingInterest -590M -88M -169M 270M 1 234M
netIncomeFromContinuingOperations 4 586M 8 368M 4 327M 7 989M 7 201M
netIncomeFromDiscontinuedOperations 0 0 0 0 -9M
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 4 614M 8 344M 4 311M 8 001M 7 179M
epsDiluted 3.66 6.47 3.26 5.95 5.46

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803
fillingDate 2025-10-29 2025-07-31 2024-11-06 2024-08-07 2024-05-01 2023-11-01 2023-08-02 2023-05-03 2022-11-02
acceptedDate 2025-10-29 06:34:58 2025-07-31 06:34:19 2025-02-12 06:47:38 2024-11-06 06:35:35 2024-08-07 06:35:29 2024-05-01 06:40:00 2024-02-07 06:52:35 2023-11-01 06:38:24 2023-08-02 06:36:58 2023-05-03 06:38:46 2023-02-08 06:37:38 2022-11-02 06:36:26 2022-02-09 06:37:35 2021-02-16 06:47:54
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 9 155M 11 787M 8 586M 6 875M 12 561M 9 801M 8 196M 13 043M 13 807M 14 618M 12 945M 17 197M 9 408M 7 854M
shortTermInvestments 2 134M 2 386M 2 407M 2 805M 3 755M 3 288M 3 259M 3 145M 3 080M 3 102M 2 778M 2 792M 3 117M 3 000M
cashAndShortTermInvestments 11 289M 14 216M 10 993M 9 680M 16 316M 13 089M 11 455M 16 188M 16 887M 17 720M 15 723M 19 989M 12 525M 10 854M
netReceivables 43 857M 40 651M 36 469M 36 179M 32 385M 32 217M 35 227M 32 927M 29 546M 28 331M 27 276M 26 565M 24 431M 21 742M
inventory 18 962M 17 447M 18 107M 17 649M 16 068M 16 346M 18 025M 17 954M 17 291M 18 263M 19 090M 18 058M 17 760M 18 496M
otherCurrentAssets 3 001M 3 335M 3 076M 3 835M 5 183M 5 821M 3 151M 3 074M 3 325M 3 767M 3 544M 2 231M 5 292M 5 277M
totalCurrentAssets 77 109M 75 649M 68 645M 67 343M 69 952M 67 473M 67 858M 70 143M 67 756M 68 706M 65 633M 68 341M 60 008M 56 369M
propertyPlantEquipmentNet 28 109M 28 337M 28 937M 30 871M 29 933M 30 082M 30 435M 30 586M 30 704M 30 532M 30 745M 30 896M 32 018M 33 335M
goodwill 85 478M 91 203M 91 272M 91 272M 91 272M 91 272M 91 272M 91 261M 91 260M 84 057M 78 150M 78 086M 79 121M 79 552M
intangibleAssets 25 984M 26 224M 27 323M 27 817M 28 311M 28 770M 29 234M 29 624M 30 118M 26 368M 24 803M 25 157M 29 026M 31 142M
goodwillAndIntangibleAssets 111 462M 117 427M 118 595M 119 089M 119 583M 120 042M 120 506M 120 885M 121 378M 110 425M 102 953M 103 243M 108 147M 110 694M
longTermInvestments 31 750M 30 053M 28 934M 28 939M 25 287M 24 074M 23 019M 21 667M 22 114M 21 612M 21 096M 20 565M 23 025M 20 812M
taxAssets 0 0 0 3 632M 4 052M 4 184M 0 4 250M 4 588M 4 095M 0 0 0 0
otherNonCurrentAssets 6 897M 6 877M 8 104M 2 553M 3 674M 3 888M 7 910M 3 775M 3 531M 3 960M 7 848M 8 167M 9 801M 9 505M
totalNonCurrentAssets 178 218M 182 694M 184 570M 185 084M 182 529M 182 270M 181 870M 181 163M 182 315M 170 624M 162 642M 162 871M 172 991M 174 346M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 255 327M 258 343M 253 215M 252 427M 252 481M 249 743M 249 728M 251 306M 250 071M 239 330M 228 275M 231 212M 232 999M 230 715M
accountPayables 60 947M 17 258M 15 892M 15 713M 14 416M 13 717M 14 897M 14 874M 13 367M 12 527M 14 838M 13 925M 12 544M 11 138M
shortTermDebt 7 237M 11 106M 5 743M 7 622M 5 642M 8 356M 2 972M 3 873M 4 108M 3 457M 1 778M 3 050M 4 205M 5 440M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 39 154M 128M 59 007M 0 56 618M 55 246M 0 0 3 508M 0 0
otherCurrentLiabilities 24 511M 65 798M 1 183M 61 292M 61 328M 2 239M 2 467M 6 188M 6 485M 59 070M 2 817M 51 926M 5 604M 5 827M
totalCurrentLiabilities 92 695M 94 162M 84 609M 84 627M 81 386M 83 319M 79 189M 81 553M 79 206M 75 054M 69 421M 72 409M 67 807M 62 017M
longTermDebt 74 515M 71 618M 60 527M 75 082M 78 180M 73 436M 58 638M 76 223M 78 028M 73 021M 50 476M 68 022M 51 971M 59 207M
deferredRevenueNonCurrent 0 0 0 0 15 537M 3 271M 0 3 200M 3 267M 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 3 547M 3 603M 3 806M 3 632M 4 052M 4 184M 4 311M 4 250M 4 588M 4 095M 4 016M 3 508M 6 270M 6 794M
otherNonCurrentLiabilities 11 460M 11 409M 13 644M 13 980M 13 752M 11 383M 14 920M 11 570M 11 980M 15 580M 15 793M 67 309M 13 393M 14 239M
totalNonCurrentLiabilities 89 522M 86 630M 92 876M 92 694M 95 984M 92 274M 93 903M 95 243M 97 863M 92 696M 87 085M 87 792M 89 811M 98 997M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 14 007M 16 234M 16 650M 17 170M 17 448M 17 648M 17 775M 18 182M 18 315M 18 250M 18 478M 18 861M 19 823M 20 395M
totalLiabilities 182 217M 180 792M 177 485M 177 321M 177 370M 175 593M 173 092M 176 796M 177 069M 167 750M 156 506M 160 201M 157 618M 161 014M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 50 181M 18M 18M 49 510M 18M 49 209M 48 992M 48 829M 48 649M 48 306M 48 193M 48 047M 47 377M 46 513M
retainedEarnings 59 107M 63 936M 62 837M 62 038M 62 797M 61 873M 61 604M 60 343M 58 868M 57 753M 56 398M 54 571M 54 906M 49 640M
accumulatedOtherComprehensiveIncomeLoss 416M 272M -120M 209M -319M -341M -297M -1 004M -858M -875M -1 264M -1 609M 965M 1 414M
othertotalStockholdersEquity -36 776M 13 153M -36 813M 12 434M -36 773M -33 831M -33 933M -33 802M -30 326M
totalStockholdersEquity 72 928M 77 379M 75 560M 74 944M 74 930M 73 968M 76 461M 74 337M 72 726M 71 382M 71 469M 70 683M 75 075M 69 389M
totalEquity 73 110M 77 551M 75 730M 75 106M 75 111M 74 150M 76 636M 74 510M 73 002M 71 382M 71 769M 70 683M 75 381M 69 701M
totalLiabilitiesAndStockholdersEquity 255 327M 258 343M 252 427M 252 481M 249 743M 251 306M 250 071M 239 330M 231 212M
minorityInterest 182M 172M 170M 162M 181M 182M 175M 173M 276M 198M 300M 0 306M 312M
totalLiabilitiesAndTotalEquity 255 327M 258 343M 253 215M 252 427M 252 481M 249 743M 249 728M 251 306M 250 071M 239 330M 228 275M 231 212M 232 999M 230 715M
totalInvestments 33 884M 32 439M 31 341M 31 744M 29 042M 27 362M 26 278M 21 667M 22 114M 21 612M 23 874M 23 357M 26 142M 23 812M
totalDebt 81 752M 82 724M 82 920M 82 704M 83 822M 81 792M 79 385M 80 096M 82 136M 76 478M 70 732M 71 072M 75 999M 85 042M
netDebt 72 654M 70 937M 74 334M 75 829M 71 261M 71 991M 71 189M 67 053M 68 329M 61 860M 57 787M 53 875M 66 591M 77 188M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-12 2024-02-07 2023-02-08 2022-02-09 2021-02-16
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 14 612M 15 622M 11 659M 10 469M 9 729M
otherReceivables 21 857M 19 605M 15 617M 13 962M 12 013M
prepaids 0 0 0 0 0
totalPayables 55 122M 49 820M 44 403M 38 682M 34 869M
otherPayables 39 230M 34 923M 29 565M 26 138M 23 731M
accruedExpenses 20 810M 22 189M 18 745M 17 670M 14 243M
capitalLeaseObligationsCurrent 1 751M 1 741M 1 678M 1 646M 1 638M
capitalLeaseObligationsNonCurrent 14 899M 16 034M 16 800M 18 177M 18 757M
treasuryStock -36 818M -33 838M -31 858M -28 173M -28 178M
additionalPaidInCapital 49 643M 0 0 0 0
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS CVS
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803 64 803
fillingDate 2025-10-29 2025-07-31 2024-11-06 2024-08-07 2024-05-01 2023-11-01 2023-08-02 2023-05-03 2022-11-02
acceptedDate 2025-10-29 06:34:58 2025-07-31 06:34:19 2025-02-12 06:47:38 2024-11-06 06:35:35 2024-08-07 06:35:29 2024-05-01 06:40:00 2024-02-07 06:52:35 2023-11-01 06:38:24 2023-08-02 06:36:58 2023-05-03 06:38:46 2023-02-08 06:37:38 2022-11-02 06:36:26 2022-02-09 06:37:35 2021-02-16 06:47:54
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -2 800M 1 021M 4 586M 71M 1 770M 1 124M 8 368M 2 265M 1 914M 2 142M 4 327M -3 409M 7 989M 7 192M
depreciationAndAmortization -2 325M 1 171M 4 597M 1 161M 1 151M 1 138M 4 366M 1 127M 1 104M 1 001M 4 224M 1 056M 4 486M 4 441M
deferredIncomeTax 283M -114M -572M -571M -124M -217M -676M -447M -68M 155M -2 029M -1 969M -402M -570M
stockBasedCompensation -126M 136M 540M 133M 133M 137M 588M 154M 204M 103M 447M 105M 484M 400M
changeInWorkingCapital -1 571M -309M 109M -2 379M 161M 2 721M 15M -732M 2 754M 4 037M 6 818M 10 819M 3 857M 3 159M
accountsReceivables -3 398M -1 086M -1 301M -2 798M -210M 3 008M -6 260M -3 116M -53M -751M -2 971M 678M -2 703M -1 510M
inventory -1 653M -51M -102M -147 406M 277M 1 660M 1 233M -495M 972M 828M -1 435M -884M 735M -973M
accountsPayables 1 989M 814M 2 335M -519M 1 929M -1 410M 3 618M 2 584M 1 085M -1 203M 4 260M 1 317M 2 898M 2 769M
otherWorkingCapital 1 491M 14M -823M 148 344M -1 835M -537M 1 424M 295M 750M 5 163M 6 964M 9 708M 2 927M 2 873M
otherNonCashItems 7 335M -8M -153M 840M 437M -1 616M 765M 349M 0 0 2 390M 2 521M 1 851M 1 243M
netCashProvidedByOperatingActivities 796M 1 897M 9 107M -745M 3 089M 4 903M 13 426M 2 716M 5 908M 7 438M 16 177M 9 123M 18 265M 15 865M
investmentsInPropertyPlantAndEquipment -698M -607M -2 781M -670M -638M -705M -3 031M -545M -591M -984M -2 727M -580M -2 520M -2 437M
acquisitionsNet 139M -119M -95M -12M -48M -25M -16 612M -18M -9 380M -7 094M -1 388M 9M -146M -26M
purchasesOfInvestments -3 859M -3 634M -15 191M -5 896M -3 236M -3 545M -9 043M -2 126M -2 141M -2 358M -7 746M -1 429M -9 963M -9 639M
salesMaturitiesOfInvestments 2 774M 3 332M 10 353M 3 216M 2 265M 2 153M 7 729M 1 907M 1 749M 1 891M 6 729M 1 175M 7 246M 6 467M
otherInvestingActivites -443M 4M 15M 32M 28M 11M 1 000 000 31M 20M
netCashUsedForInvestingActivites -2 087M -1 024M -3 347M -1 625M -2 094M -771M -10 362M -8 514M -805M
debtRepayment -671M 1 761M -869M 2 221M -2 501M -947M -6 425M -362M -2 666M
commonStockIssued 117M 47M 0 0 203M -878M 10 971M 96M 0
commonStockRepurchased 0 0 -3 023M 1 000 000 3M -3 027M -2 012M 3M 2M -2 018M -3 500M 0 0 0
dividendsPaid -846M -866M -837M -858M -840M -779M -795M -779M -726M
otherFinancingActivites 18M -136M 117M -117M -64M -96M -127M 5 789M 174M
netCashUsedProvidedByFinancingActivities -1 382M 806M -1 588M 1 249M -1 227M -2 697M 3 626M 2 726M -3 218M
effectOfForexChangesOnCash 0 0 0 0 0 0 0 0 0 0 0 0 0 0
netChangeInCash -2 673M 1 679M 359M -5 421M 2 709M 1 582M -4 780M -752M -828M 1 650M 614M 5 100M 1 648M 2 635M
cashAtEndOfPeriod 9 352M 12 025M 8 884M 7 140M 12 561M 10 107M 8 525M 13 375M 14 127M 14 955M 13 305M 17 563M 12 691M 11 043M
cashAtBeginningOfPeriod 12 025M 10 346M 8 525M 12 561M 9 852M 8 525M 13 305M 14 127M 14 955M 13 305M 12 691M 12 463M 11 043M 8 408M
operatingCashFlow 796M 1 897M 9 107M -745M 3 089M 4 903M 13 426M 2 716M 5 908M 7 438M 16 177M 9 123M 18 265M 15 865M
capitalExpenditure -698M -607M -2 781M -670M -638M -705M -3 031M -545M -591M -984M -2 727M -580M -2 520M -2 437M
freeCashFlow 98M 1 290M 6 326M -1 415M 2 451M 4 198M 10 395M 2 171M 5 317M 6 454M 13 450M 8 543M 15 745M 13 428M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-12 2024-02-07 2023-02-08 2022-02-09 2021-02-16
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 101M 68M 85M 122M 101M
netCashProvidedByInvestingActivities -7 613M -20 889M -5 047M -5 261M -5 534M
netDebtIssuance 5 059M 7 932M -4 211M -9 267M -5 673M
longTermNetDebtIssuance 3 140M 7 732M -4 211M -9 267M -5 673M
shortTermNetDebtIssuance 1 919M 200M 0 0 0
netStockIssuance -3 023M -2 012M -3 500M 0 0
netCommonStockIssuance -3 023M -2 012M -3 500M 0 0
commonStockIssuance 0 0 0 0 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -3 373M -3 132M -2 907M -2 625M -2 624M
commonDividendsPaid -3 373M -3 132M -2 907M -2 625M -2 624M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 202M -105M 102M 536M 601M
netCashProvidedByFinancingActivities -1 135M 2 683M -10 516M -11 356M -7 696M
incomeTaxesPaid 0 0 0 0 0
interestPaid 0 0 0 0 0

Earning call transcript

2025 q3
2025-10-29 ET (fiscal 2025 q3)
2025 q2
2025-08-06 ET (fiscal 2025 q2)
2025 q1
2025-05-01 ET (fiscal 2025 q1)
2024 q4
2025-02-12 ET (fiscal 2024 q4)
2024 q3
2024-11-06 ET (fiscal 2024 q3)
2024 q2
2024-08-07 ET (fiscal 2024 q2)
2024 q1
2024-05-01 ET (fiscal 2024 q1)
2023 q4
2024-02-07 ET (fiscal 2023 q4)
2023 q3
2023-11-01 ET (fiscal 2023 q3)
2023 q2
2023-08-02 ET (fiscal 2023 q2)
2023 q1
2023-05-03 ET (fiscal 2023 q1)
2022 q4
2023-02-08 ET (fiscal 2022 q4)
2022 q3
2022-11-02 ET (fiscal 2022 q3)
2022 q2
2022-08-03 ET (fiscal 2022 q2)
2022 q1
2022-05-04 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2026-02-10 06:36 ET
CVS Health reported for 2025 q4
SEC form 8
2026-02-10 06:31 ET
CVS Health published news for 2025 q4
SEC form 8
2026-02-10 06:31 ET
CVS Health reported for 2025 q4
SEC form 8
2025-12-09 11:33 ET
CVS Health published news for 2025 q3
SEC form 8
2025-12-09 11:33 ET
CVS Health published news for 2025 q3
SEC form 8
2025-11-20 16:18 ET
CVS Health published news for 2025 q3
SEC form 8
2025-11-20 16:18 ET
CVS Health published news for 2025 q3
SEC form 10
2025-10-29 10:34 ET
CVS Health reported for 2025 q3
SEC form 8
2025-10-29 10:32 ET
CVS Health published news for 2025 q3
SEC form 8
2025-10-29 10:32 ET
CVS Health reported for 2025 q3
SEC form 8
2025-09-22 20:19 ET
CVS Health published news for 2025 q2
SEC form 8
2025-09-22 20:19 ET
CVS Health published news for 2025 q2
SEC form 8
2025-08-15 16:10 ET
CVS Health published news for 2025 q2
SEC form 8
2025-08-15 16:10 ET
CVS Health published news for 2025 q2
SEC form 8
2025-08-15 16:10 ET
CVS Health published news for 2025 q2
SEC form 8
2025-08-15 16:10 ET
CVS Health published news for 2025 q2
SEC form 8
2025-08-15 16:10 ET
CVS Health published news for 2025 q2
SEC form 8
2025-08-15 16:10 ET
CVS Health published news for 2025 q2
SEC form 8
2025-08-15 16:10 ET
CVS Health published news for 2025 q2
SEC form 10
2025-07-31 10:34 ET
CVS Health reported for 2025 q2
SEC form 8
2025-07-31 10:31 ET
CVS Health published news for 2025 q2
SEC form 8
2025-07-31 10:31 ET
CVS Health reported for 2025 q2
SEC form 10
2025-05-01 10:35 ET
CVS Health reported for 2025 q1
SEC form 8
2025-05-01 10:32 ET
CVS Health published news for 2025 q1
SEC form 8
2025-05-01 10:32 ET
CVS Health reported for 2025 q1
SEC form 10
2025-05-01 00:00 ET
CVS Health reported for 2025 q1
SEC form 10
2025-02-12 06:47 ET
CVS Health reported for 2024 q4
SEC form 8
2025-02-12 06:32 ET
CVS Health published news for 2024 q4
SEC form 8
2025-02-12 06:32 ET
CVS Health reported for 2024 q4
SEC form 10
2025-02-12 00:00 ET
CVS Health reported for 2024 q4
SEC form 10
2024-11-06 06:35 ET
CVS Health reported for 2024 q3
SEC form 8
2024-11-06 06:33 ET
CVS Health published news for 2024 q3
SEC form 8
2024-11-06 06:33 ET
CVS Health reported for 2024 q3
SEC form 8
2024-10-18 00:00 ET
CVS Health published news for 2024 q3
SEC form 8
2024-10-18 00:00 ET
CVS Health published news for 2024 q3
SEC form 10
2024-08-07 06:35 ET
CVS Health reported for 2024 q2
SEC form 8
2024-08-07 06:33 ET
CVS Health published news for 2024 q2
SEC form 8
2024-08-07 06:33 ET
CVS Health reported for 2024 q2
SEC form 10
2024-08-07 00:00 ET
CVS Health published news for 2024 q2
SEC form 10
2024-05-01 06:40 ET
CVS Health reported for 2024 q1
SEC form 8
2024-05-01 06:32 ET
CVS Health published news for 2024 q1
SEC form 8
2024-05-01 06:32 ET
CVS Health reported for 2024 q1
SEC form 10
2024-05-01 00:00 ET
CVS Health published news for 2024 q1
SEC form 10
2024-02-07 00:00 ET
CVS Health reported for 2023 q4
SEC form 8
2024-02-07 00:00 ET
CVS Health published news for 2023 q4
SEC form 8
2024-02-07 00:00 ET
CVS Health reported for 2023 q4
SEC form 8
2024-01-05 00:00 ET
CVS Health published news for 2023 q4
SEC form 8
2024-01-05 00:00 ET
CVS Health published news for 2023 q4
SEC form 10
2023-11-01 06:38 ET
CVS Health reported for 2023 q3
SEC form 8
2023-11-01 06:35 ET
CVS Health reported for 2023 q3
SEC form 10
2023-11-01 00:00 ET
CVS Health published news for 2023 q3
SEC form 10
2023-08-02 06:36 ET
CVS Health reported for 2023 q2
SEC form 6
2023-08-02 06:34 ET
CVS Health reported for 2023 q2
SEC form 10
2023-08-02 00:00 ET
CVS Health published news for 2023 q2
SEC form 8
2023-08-02 00:00 ET
CVS Health published news for 2023 q2
SEC form 6
2023-07-20 16:10 ET
CVS Health published news for 2023 q2
SEC form 6
2023-06-27 16:44 ET
CVS Health published news for 2023 q1
SEC form 6
2023-06-02 16:09 ET
CVS Health published news for 2023 q1
SEC form 10
2023-05-03 00:00 ET
CVS Health published news for 2023 q1
SEC form 8
2023-05-03 00:00 ET
CVS Health published news for 2023 q1
SEC form 6
2023-03-30 07:46 ET
CVS Health published news for 2022 q4
SEC form 6
2023-02-21 16:06 ET
CVS Health published news for 2022 q4
SEC form 6
2023-02-15 16:08 ET
CVS Health published news for 2022 q4
SEC form 6
2023-02-08 17:28 ET
CVS Health published news for 2022 q4
SEC form 10
2023-02-08 06:37 ET
CVS Health published news for 2022 q4
SEC form 6
2023-02-08 06:32 ET
CVS Health published news for 2022 q4
SEC form 6
2023-02-08 06:10 ET
CVS Health published news for 2022 q4
SEC form 10
2023-02-08 00:00 ET
CVS Health reported for 2022 q4
SEC form 8
2023-02-08 00:00 ET
CVS Health reported for 2022 q4
SEC form 6
2023-01-23 16:13 ET
CVS Health published news for 2022 q4
SEC form 6
2023-01-09 06:27 ET
CVS Health published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
CVS Health published news for 2022 q4
SEC form 6
2022-11-21 16:34 ET
CVS Health published news for 2022 q3
SEC form 10
2022-11-02 06:36 ET
CVS Health published news for 2022 q3
SEC form 6
2022-11-02 06:33 ET
CVS Health published news for 2022 q3
SEC form 10
2022-11-02 00:00 ET
CVS Health reported for 2022 q3
SEC form 8
2022-11-02 00:00 ET
CVS Health reported for 2022 q3
SEC form 6
2022-10-20 06:45 ET
CVS Health published news for 2022 q3
SEC form 6
2022-10-06 17:02 ET
CVS Health published news for 2022 q3
SEC form 6
2022-09-13 06:55 ET
CVS Health published news for 2022 q2
SEC form 6
2022-09-13 06:30 ET
CVS Health published news for 2022 q2
SEC form 6
2022-09-06 06:17 ET
CVS Health published news for 2022 q2
SEC form 6
2022-09-06 06:14 ET
CVS Health published news for 2022 q2
SEC form 10
2022-08-03 06:35 ET
CVS Health published news for 2022 q2
SEC form 6
2022-08-03 06:33 ET
CVS Health published news for 2022 q2
SEC form 10
2022-08-03 00:00 ET
CVS Health reported for 2022 q2
SEC form 8
2022-08-03 00:00 ET
CVS Health reported for 2022 q2
SEC form 6
2022-08-02 16:10 ET
CVS Health published news for 2022 q2
SEC form 6
2022-07-15 16:22 ET
CVS Health published news for 2022 q2
SEC form 6
2022-06-23 17:03 ET
CVS Health published news for 2022 q1
SEC form 6
2022-06-09 06:32 ET
CVS Health published news for 2022 q1
SEC form 6
2022-05-16 16:40 ET
CVS Health published news for 2022 q1
SEC form 6
2022-05-16 16:27 ET
CVS Health published news for 2022 q1
SEC form 10
2022-05-04 06:35 ET
CVS Health published news for 2022 q1
SEC form 6
2022-05-04 06:31 ET
CVS Health published news for 2022 q1
SEC form 10
2022-05-04 00:00 ET
CVS Health reported for 2022 q1
SEC form 8
2022-05-04 00:00 ET
CVS Health reported for 2022 q1
SEC form 6
2022-04-01 16:32 ET
CVS Health published news for 2022 q1
SEC form 6
2022-03-30 08:38 ET
CVS Health published news for 2021 q4
SEC form 6
2022-03-25 07:38 ET
CVS Health published news for 2021 q4
SEC form 6
2022-03-10 08:13 ET
CVS Health published news for 2021 q4
SEC form 10
2022-02-09 06:37 ET
CVS Health published news for 2021 q4
SEC form 6
2022-02-09 06:33 ET
CVS Health published news for 2021 q4
SEC form 10
2022-02-09 00:00 ET
CVS Health published news for 2021 q4
SEC form 8
2022-02-09 00:00 ET
CVS Health published news for 2021 q4
SEC form 6
2022-01-11 06:31 ET
CVS Health published news for 2021 q4
SEC form 8
2022-01-11 00:00 ET
CVS Health published news for 2021 q4
SEC form 6
2021-12-13 16:50 ET
CVS Health published news for 2021 q3
SEC form 6
2021-12-09 06:43 ET
CVS Health published news for 2021 q3
SEC form 6
2021-11-18 09:06 ET
CVS Health published news for 2021 q3
SEC form 10
2021-11-03 06:46 ET
CVS Health published news for 2021 q3
SEC form 6
2021-11-03 06:43 ET
CVS Health published news for 2021 q3
SEC form 10
2021-11-03 00:00 ET
CVS Health published news for 2021 q3
SEC form 8
2021-11-03 00:00 ET
CVS Health published news for 2021 q3
SEC form 6
2021-08-23 16:27 ET
CVS Health published news for 2021 q2
SEC form 6
2021-08-18 16:07 ET
CVS Health published news for 2021 q2
SEC form 6
2021-08-11 16:24 ET
CVS Health published news for 2021 q2
SEC form 6
2021-08-09 08:33 ET
CVS Health published news for 2021 q2
SEC form 10
2021-08-04 06:36 ET
CVS Health published news for 2021 q2
SEC form 6
2021-08-04 06:34 ET
CVS Health published news for 2021 q2
SEC form 10
2021-08-04 00:00 ET
CVS Health published news for 2021 q2
SEC form 8
2021-08-04 00:00 ET
CVS Health published news for 2021 q2
SEC form 6
2021-06-24 16:40 ET
CVS Health published news for 2021 q1
SEC form 6
2021-06-10 17:20 ET
CVS Health published news for 2021 q1
SEC form 6
2021-05-18 08:09 ET
CVS Health published news for 2021 q1
SEC form 6
2021-05-17 16:40 ET
CVS Health published news for 2021 q1
SEC form 10
2021-05-04 06:37 ET
CVS Health published news for 2021 q1
SEC form 6
2021-05-04 06:33 ET
CVS Health published news for 2021 q1
SEC form 10
2021-05-04 00:00 ET
CVS Health published news for 2021 q1
SEC form 8
2021-05-04 00:00 ET
CVS Health published news for 2021 q1
SEC form 6
2021-04-02 16:06 ET
CVS Health published news for 2021 q1
SEC form 10
2021-02-16 06:47 ET
CVS Health published news for 2020 q4
SEC form 6
2021-02-16 06:36 ET
CVS Health published news for 2020 q4
SEC form 6
2020-12-21 16:34 ET
CVS Health published news for 2020 q3
SEC form 6
2020-12-16 16:36 ET
CVS Health published news for 2020 q3
SEC form 6
2020-12-09 16:51 ET
CVS Health published news for 2020 q3
SEC form 6
2020-12-07 10:35 ET
CVS Health published news for 2020 q3
SEC form 6
2020-11-06 16:01 ET
CVS Health published news for 2020 q3
SEC form 10
2020-11-06 06:41 ET
CVS Health published news for 2020 q3
SEC form 6
2020-11-06 06:37 ET
CVS Health published news for 2020 q3